Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen

The Journal of Clinical Investigation
T F Kresina, G R Olds

Abstract

This study presents the characterization of an experimental immunotherapeutic approach for schistosomiasis utilizing antiidiotypic antibodies. Antiidiotype (31-3B6) was generated in rabbits using a protective murine monoclonal antibody 31-3B6 which recognizes a 68,000-D molecular mass glycoprotein present in extracts of Schistosomiasis mansoni adult worm homogenetics. Immunization of mice with antiidiotype (31-3B6) before S. mansoni cercariae infection resulted in protection levels ranging from 16 to 41% depending on the route of administration of antiidiotypic antibody and the use of adjuvant. Levels of protection as high as 25% could be obtained with a single injection of antiidiotype (31-3B6) without the use of adjuvant. Animals noted to be resistant to infection with S. mansoni cercariae were also noted to exhibit a humoral immune response that bound components of S. mansoni adult worm homogenetics. This induced antiantigen immune response was shown to bind to the surface of S. mansoni schistosoma by indirect immunofluorescence. Further characterization of the induced antiantigen response showed that a portion (3-32%) of the induced humoral immune response portrayed the binding specificities of the murine monoclonal antibod...Continue Reading

References

Feb 1, 1977·Experimental Parasitology·P M KnopfJ A Reasoner
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C BruckM I Greene
Jan 1, 1986·International Reviews of Immunology·T Kieber-EmmonsH Kohler
Feb 1, 1985·Proceedings of the Society for Experimental Biology and Medicine·H KohlerC Bona
Nov 20, 1987·Science·A CapronA E Butterworth
Dec 1, 1974·Experimental Parasitology·F J Ramalho-PintoJ Pellegrino
Jan 1, 1966·International Archives of Allergy and Applied Immunology·P J McConahey, F J Dixon
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·H C Ertl, R W Finberg
Oct 1, 1984·The Journal of Experimental Medicine·A H SharpeM I Greene
Feb 1, 1983·Experimental Parasitology·D A Dean
Jan 1, 1980·Immunological Reviews·G KelsoeK Rajewsky
Jan 1, 1981·Annual Review of Public Health·K S Warren
Jan 1, 1980·International Journal of Nuclear Medicine and Biology·S M Phillips, W A Reid
Apr 1, 1982·The Journal of Experimental Medicine·D L SacksA Sher

❮ Previous
Next ❯

Citations

Jul 1, 1992·Applied Biochemistry and Biotechnology·Y M GomesA F Furtado
Jan 1, 1995·International Journal for Parasitology·R BardonC Aguila
Aug 28, 1991·Journal of Immunological Methods·J L LiY J Li
Sep 1, 1996·Parasite Immunology·A V WisnewskiT F Kresina
Jan 1, 1989·Annals of the New York Academy of Sciences·A A Mahmoud
Apr 5, 2002·Fish & Shellfish Immunology·Xia YongjuanZhang Rongqing
Apr 27, 2000·Allergy·G F JoosR A Pauwels
Aug 15, 1990·International Journal of Cancer. Journal International Du Cancer·M J LosmanD M Goldenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.